Summary. Staphylococcus aureus is a major causative agent of intramammary infections in dairy cows. In this report, the pathogenesis of these infections is described. The potential role in virulence of S. aureus surface components (adhesins, protein A and capsular polysaccharides), toxins, extracellular enzymes and coagulase, and perspectives for the development of an efficient vaccine are discussed.
Introduction
Staphylococcus aureus is a gram-positive, facultatively anaerobic, non-sporulating, non-motile, catalase-positive and oxidase-negative COCCUS.~ This bacterium, which is a natural inhabitant of mammalian skin and mucous epithelia, is the causative agent of various diseases in man and domestic animals.
In man, S. aureus causes two main types of infection:2 (1) cutaneous or mucosal infections, and (2) septicaemic infections which are generally associated with visceral (abscesses, endocarditis, lung infections) or bone (osteomyelitis) infections.
In domestic animals, S. aureus is mainly involved in intramammary infections (IMI) of lactating fern ale^.^
In cows, IMI due to S. aureus, which account for 25-30 % of total IMI,4 are generally subclinical. Nevertheless, IMI cause considerable economic losses, particularly milk losses which range from 10 to 25 YO of total yield according to the intensity of inflammation and the stage of lactation when the infection O C C U~S .~ Moreover, the presence of S. aureus in raw milk used by dairy industries is a public health problem.
Current control of intramammary infections
At present, the control of S. aureus IMI is based on two types of mea~ures.~ Firstly, hygiene at milking that aims to limit the spread of IMI in herds, particularly pre-milking washing and post-milking drying of udders with individual cloths, dipping teats with antiseptic solutions after milking, and cleaning of Received 15 Feb. 1993; revised version accepted 27 July 1993. milking machines. Secondly, systematic antibiotic treatment by the intramammary route at drying-off to cure chronic subclinical IMI established during lactation and to prevent new infections during the dry period.
In practice, these measures, which are often considered constraining or expensive, are not always applied on the farm. The presently available antibiotic preparations used during lactation cure < 50% of S. aureus IMI.6 This low efficiency seems not to be due to acquired resistance but may result from the fact that some bacteria are located intracellularly, in macrophages or epithelial cells, and inaccessible to antibiotics.
In the context of the high prevalence and economic consequences of S. aureus IMI, and the relative inefficiency of control measures, the development of a vaccine against S. aureus IMI is of great interest. Numerous attempts at vaccination with live or killed bacterial cells, isolated bacterial cell walls, toxoid or killed cell-toxoid preparations, have been In several experiments, particularly those with toxoids, a reduction of the frequency and the severity of clinical 1MI has been observed. However, whatever the antigenic preparations used, protection against new infections, which is the main objective of vaccination, has never been achieved. Three major reasons can be invoked to explain these results:' (1) an incomplete knowledge of the immune defence mechanisms of the mammary gland; (2) the fact that vaccine prepared in vitro did not contain relevant antigens, i.e., those expressed in vivo and involved in virulence ; and (3) the lack of appropriate immunisation schedules.
The development of a vaccine against a bacterial infection requires a clear definition of the major virulence factors involved in the infection. Molecular genetics permits the isolation of specific genes from bacterial pathogens, the elucidation of their structure and function and the modification of their expression. A powerful approach based on Koch's postulates has been proposed as follows.l0 (1) The supposed virulence factor should be associated with pathogenic strains of the bacterial species under investigation. (2) The gene(s) encoding this supposed virulence factor should be isolated and the inactivation of the gene(s) should lead to a significant loss of virulence. (3) The reintroduction of the gene(s) of origin in the modified strain(s) should restore the virulence. During the past decade, this modern molecular approach has been developed to study virulence factors of S. aureus isolates from bovine IMI.
The purpose of this article is to review the current knowledge on the virulence factors involved in the pathogenesis of bovine S. aureus IMI and examine the prospects for a vaccine against these infections.
Contamination of the teat orifice and entry of S. aureus into the mammary gland
Intramammary infections caused by S. aureus, and also by other bacterial species, are due to the entry of bacteria through the teat canal into the mammary gland. One quarter of a cow's udder is generally infected independently of the other three.
The main reservoirs of S. aureus in herds are infected quarters and the skin of the udder and t e a t~.~-l l The presence of lesions on teat skin, such as chaps and cracks, allows persistent colonisation of the skin by S. aureus. A study on c. 800 quarters has shown that without hygienic measures during milking, the rate of teat orifice contamination by S. aureus can reach 60 % of healthy quarters compared to > 85% of quarters with teat skin lesions.12 To avoid teat trauma or lesions due to adverse milking conditions, the vacuum level and pulsation frequency of milking machines must be checked regularly and adjusted.
As S. aureus is mainly located on or in udders, the transmission of bacteria from teat to teat in the same cow or from one cow to another generally occurs during milking. The main vectors of transmission are the hands of milking staff, the cloths used to wash or dry the udder, the milking cups and contaminated milk which can flow back to the teat during milking as a consequence of sudden variations of vacuum in the milking machine (impact phen~menon).~ The role of milking in the transmission of S. aureus is confirmed by the fact that rigorous hygienic measures during milking lead to a drastic decrease in teat orifice contamination and, consequently, in the rate of new S. aureus IMI in herds.12 *13 Once the teat orifice is contaminated by S. aureus, bacteria can persist and multiply14 and then enter the teat canal either by progressive colonisation or by the impact phenomenon, particularly at the end of milking.3 Colonisation of the teat canal seems to be a necessary preliminary step for the mammary gland to be infected.15 S . aureus, together with coagulasenegative staphylococci, Corynebacterium bovis and Streptococcus agalactiae, are the micro-organisms most frequently isolated from the teat cana1,16 where they can adhere to the keratinised epithelial cells.17-It seems that the closer the bacteria colonising the teat canal are to the teat sinus, the higher is the risk of mammary infe~ti0n.l~ The contact of these bacteria with milk could allow their transfer into the teat sinus when the intramammary pressure increases (before milking or when the cow walks, lies down or stands up) and just after milking when the teat canal is di~tended.~. 2o
Colonisation of the mammary gland
Several studies have shown that it is possible to induce experimental S . aureus IMI by intramammary infusion of a low number of bacteria (< 100 cfu) through the teat 22 These observations demonstrate that milk is a good medium for growth of S. aureus, which can hydrolyse casein and ferment lactose,' and that the natural defence mechanisms of the mammary gland against infection are inefficient. Bacterial surface properties play a major role in the host-bacterium relati~nship.~~ During S. aureus IMI, surface components participate in bacterial adhesion to host mammary tissues and to resistance to phagocytosis by milk cells.
Role of adhesins
The first step in the colonisation of the mammary gland by S. aureus seems to be adhesion to epithelial cells. aureus to epithelial cells of lactiferous ducts has been confirmed in vivo by microscopic examination of sections of experimentally infected mammary glands. 28 The mechanisms of S. aureus adhesion to mammary epithelial cells are not well known. Two types of interactions could be involved : (1) non-specific physiochemical interactions, and (2) 39 These enzymes also decreased surface hydrophobicity2' and the ability of S. aureus to bind collagen3' and Fn. 37 Recently, Lindahl et aL40 purified a cell-wall associated protein of 145 kDa from a strain of S. aureus isolated from bovine IMI. This component has the ability to bind to membrane proteins of bovine milk fat globules and mammary epithelial cells.
From facts already known, it can be supposed that adhesins such as Fnbp could mediate S. aureus adhesion to epithelial cells and to micro-lesions of the mammary epithelium where basal lamina and inflammatory conjunctive tissue, which are rich in Fn and collagen, are exposed.37 In the early stages of the infection, adhesion to epithelial cells could prevent S. aureus from flowing out of the gland during milking. Then, S. aureus could disseminate in the mammary gland by adhering to rising fat g l o b~l e s l~*~' and then attach to the epithelial cells at different levels of the gland, i.e., teat sinus and lactiferous sinus and ducts.26
Expression of antl'phagocytic factors by S. aureus
The main defence mechanism of the mammary gland against infections by S. aureus is phagocytosis by polymorphonuclear neutrophil leucocytes (PMNL).42 Schalm et ~1 . ~~ have demonstrated that the induction of neutropaenia by continuous intravenous injection of equine anti-bovine leucocyte serum led to a conversion of S. aureus IMI from subclinical to the acute gangrenous form. Moreover, Postle et a1. 22 failed to induce experimental S. aureus IMI in quarters with milk somatic cell counts (SCC) greater than 6 x lo5 cells/ml.
The SCC of milk from healthy quarters is generally < 105cells/inl. Infection of the mammary gland entails a flow of leucocytes, mostly PMNL, from blood through the mammary parenchyma into milk. 44 After experimental intramammary inoculation with S. aureus, the SCC of milk begins to increase 1-3 h after inoculation and can reach several million cells/ml within 24-48 h.28945 Phagocytosis of bacteria by PMNL includes recognition, ingestion and intracellular destruction of bacteria.46 Membrane receptors of PMNL can bind non-specifically to bacterial surface components through lectin-carbohydrate-like interactions but recognition of bacteria and subsequent activation of PMNL are much more efficient when they are mediated by opsonins. Opsonisation of S. aureus involves anti bodies, particularly those specific to peptidoglycan epitopes, and the C3b component of ~o m p l e m e n t .~~ The C3b component is generated by activation of complement by the classic or alternate pathways, either directly by surface components of S. aureus such as peptidoglycan or teichoic or by immune complexes between peptidoglycan and specific antibodies, particularly of the IgG i~o t y p e .~~ Fixation of immunoglobulins (associated to C3b or not) by their antibody site on bacteria and by their Fc fragment on PMNL surface receptors activates the ingestion of bacteria by PMNL. In ruminants, most of the membrane Fc receptors on PMNL are specific to IgG2 i s~t y p e .~~~
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The milk of a healthy quarter has a low concentration of opsonins, complement5' and immunoglobulins (0-8-1 mg/ml, i.e., 25-30 times less than in serum). 52 The milk content of IgG2, which is the major isotype involved in opsonisation, is particularly low (0-05-0-06 mg/ml). The inflammation of the mammary gland during S. aureus IMI includes both PMNL recruitment and exudation of plasma through the mammary parenchyma into milk. Milk concentrations of IgG1, IgG2 and complement Nevertheless, this inflammation does not result in the total elimination of bacteria but only in a partial control of the infection which evolves to a chronic subclinical form that reflects a balance between multiplication of bacteria and the mammary defences. This balance can be explained on one hand by the low efficiency of phagocytosis due to the ingestion of casein and fat globules by PMNL56y57 and to the low level in milk of opsonising antibodies specific to S. aureus and, on the other hand, by the production of antiphagocytic factors such as protein A and a capsule by S. aureus. Protein A . Staphylococcal protein A (SpA) is a protein bound to the surface of the bacterial cell wall that has the ability to bind IgG of numerous mammalian species (man, mouse, rabbit, ruminants) by the Fc f~a g m e n t .~~?~'
Using human IgG as a source of opsonins, Dossett et a1. 60 have demonstrated that bacterial bound or free soluble SPA inhibited phagocytosis of S. aureus by human PMNL in vitro. Nevertheless, this antiphagocytic effect seems to depend on the relative availability of both antibodies and complement. In the presence of human IgG-deficient serum, opsonisation of SpA high-producing strains is more efficient than that of low-producing strains whereas the converse has been observed with normal human serum or purified IgG as opsonins. 60, 61 SPA, which has been detected on 50-60 YO of strains isolated from bovine IMI,62*63 can react strongly with bovine IgG2, but weakly with IgG1. 64 In milk from a healthy quarter, the concentration of IgG2, the major isotype involved in opsonisation, is very low. Consequently, SpA may play a minor role in S. aureus virulence, at least during the early stages of bovine IMI. Postle et a1.22 reported a highly significant negative correlation between the amount of SpA on S. aureus strains (12 strains studied) and their experimental pathogenicity in cows. This was postulated to be due to complement activation by SPA that released chemotactic (C3a and C5a components) and opsonising (C3b) factors. Conversely, during later stages of IMI when the opsonising IgG2 milk content increases as a consequence of plasma inflammatory exudation, the antiphagocytic effect of SPA could be expressed. Nevertheless, this hypothesis has still to be proved. Finally, it is noteworthy that Jonsson et al. 65 observed no difference in virulence for the mouse mammary gland between an SpA low-producing strain, a high-producing mutant and a SPA-negative mutant carrying a plasmid containing the complete gene for SPA. With the same mouse model, Foster et a1.66 observed that SPA-deficient mutants were less virulent than a parental strain that produced a high amount of SPA. The discrepancy between these two studies could be due to the method used to isolate mutants-chemical mutagenesis, that can induce pleiotropy in the former study and site-specific mutagenesis in the latter one.
Capsule. The capsule is defined as a polysaccharide layer covering the cell wall.67 When observed by light or electronmicroscopy in the presence of Indian ink, it appears as a white halo surrounding the bacteria.68 Capsulate S. aureus strains produce diffuse colonies in serum-soft agar (SSA), a medium containing normal rabbit serum 1 %, whereas non-capsulate strains produce compact Two studies (each with about 800 strains) have demonstrated that only 5 % of S. aureus strains isolated from human infections produce a capsule as defined by the microscopic Indian ink and the SSA technique^.^^.^^
The existence of a capsule on S. aureus strains isolated from bovine IMI is a much debated matter.
Several studies have shown that most strains (85-95 YO) produce diffuse colonies when inoculated directly from infected milk into SSA.72-74 In these studies, SSA was prepared from a modified staphylococcus medium 110 (mod 110) which is enriched with mannitol, lactose and sodium chloride and is known to enhance the production of extracellular polysaccharides by S. a~reus.~' Nevertheless, the reliability of the SSA technique for demonstrating capsulation has been contested. On strains isolated from IMI that produced diffuse colonies in SSA, and Rather et al.76 failed to observe a capsule by light microscopy. They concluded that strains from bovine IMI were not capsulate75 or that these strains do not produce capsule but slime,76 a polysaccharide component loosely bound to the bacterial surface. 67 Watson's team in Australia has observed that S. aureus strains isolated from bovine or ovine IMI produce a surface component when cultivated in vivo in the peritoneal cavity of sheep but not in vitro in classical media, which they called a pseudo~apsule.~~~ 78 The pseudocapsule is associated with the bacterial surface but is not visible by light microscopy and, therefore, cannot be classified as a classical capsule. Watson and Watson79 demonstrated by electronmicroscopy that the pseudocapsule is also produced in vivo during IMI and in vitro when S. aureus is cultivated in nutrient broth containing bovine, ovine or caprine milk whey. However, this pseudocapsule has never been purified and its biochemical nature and structure have never been demonstrated. Therefore, it cannot be related to the well defined capsular polysaccharides described by Karakawa and Vanns0 (see below). Strains producing a pseudocapsule are more virulent for mice and have a higher resistance to phagocytosis by PMNL.78 Vaccination of cowss1 or ewes82 with a pseudocapsule-producing strain induced serum pseudocapsular antibodies and increased the resistance of vaccinated animals to experimental infections by S. aureus, as assessed by the severity of clinical signs and milk production. However, pseudocapsular antigens used to detect antibodies induced by vaccination were prepared by abrasion of the vaccine strain surface with glass beads and removal of SpA by elution through an affinity column of Sepharose 4B to which purified rabbit IgG was coupled.81~82 It is likely that the extract is a complex multi-antigenic mixture and, consequently, the partial protection observed cannot be ascribed to any single factor.
It has been demonstrated that S. aureus strains isolated from human infections produce capsular polysaccharides (CP) that belong to 11 different serotypes.80,83 Several serological surveys with rabbit polyclonal seras3, 84 or mouse monoclonal antibodies ( M A~S ) '~~~~ have shown that 70-80 Yo of strains from human sources belong to two serotypes, 5 and 8. Types 5 and 8 CP have been p~r i f i e d ,~~,~' visualised on bacterial surfaces by electronmicroscopy with goldlabelled MAbss5 and their chemical structures have been defined :" they are heteropolymers of N-acetylfucosamine and N-acetylmannuronic acid with 0-acetyl groups, the location of which varies according to serotype. These CP do not constitute classical capsules, i.e., visible by light microscopy, but microcapsules. Strains producing CP are resistant to phago-cytosis in vitro by human PMNL in the presence of heat-inactivated normal human serum but this resistance is suppressed in the presence of CP-specific rabbit serum or mouse MA~S.~O By using anti-type 5 and 8 MAbs, we have demonstrated recently that these CP types account for > 50 YO and for c. 20 YO of 2 12 S. aureus strains isolated from bovine IMI, re~pectively.~' These two CP types are also prevalent amongst S. aureus strains from caprine and ovine IMI." Most CP-producing strains exhibited diffuse colonies in mod 110-SSA with a masking of cell-wall-associated components such as SpA and teichoic acid.92 Nevertheless, no capsule was observed by the microscopic Indian ink technique. It seems that most S. aureus strains from IMI express a capsule that is sufficiently thick to mask bacterial surface antigen but not thick enough to be detected by light After cultivation on bovine milk agar, S. aureus strains isolated from IMI become more resistant to phagocytosis in vitro by bovine PMNL in the presence of normal, i.e., complement-containing, bovine serum than after cultivation on conventional media. This resistance is also associated with cellsurface masking ascribable to CP expression, as demonstrated by agglutination with specific M A~s . '~ With an enzyme-linked immunosorbent assay (ELISA), we have shown that normal bovine serum contains large amounts of anti-teichoic acid antibodies but very low amounts of anti-CP a n t i b~d i e s .~~ Consequently, it can be concluded either that CP could act as a barrier to the binding of serum opsonins to S. aureus surface,95 or, if the capsule is permeable to opsonins, as suggested previo~sly,~~ CP could prevent their interaction with PMNL-specific membrane receptors. 67 Our results are not consistent with those obtained by Xu et aLg7 These authors have shown that type 5 and 8 micro-capsulate strains did not resist phagocytosis by human PMNL in the presence of normal human serum. These discrepancies could be explained by the fact that our experimentsg4 were performed with strains of bovine origin cultivated in the presence of milk that enhanced the expression of CP, as demonstrated by the shielding of bacterial surface, whereas Xu et aLg7 used strains from man cultivated in conventional Columbia broth. In the latter case, it can be supposed that the microcapsule was not thick enough to impede the interaction between cell-wall associated C3b and receptors to C3b on PMNL.
Hypothetic kinetics of in-vivo expression of S. aureus surface components
Although the kinetics of expression of surface components have never been investigated, it can be supposed that during the first stages of infection S. aureus produces hydrophobic surface proteins, particularly receptors for host components, that allow it to adhere to mammary epithelium and milk fat globules and thus to disseminate in the gland.29*30940 Then, during exposure to milk, S. aureus could express CP that prevents phagocytosis by impairing interactions between bacteria and PMNL mediated by opsonins as described above,67 or because of their hydrophilic nature.g8 Expression of capsule by S. aureus during IMI has been demonstrated clearly by detection of CP by ELISA with MAbs in milk from infected mammary glands" and by electronmicroscopy studies of strains separated from IMI milk samples by magnetic particles coated with anticapsulate s. aureus antibodies.loo These hypotheses are supported by the following observations. The binding of Fn and collagen has been found to be lower for S. aureus grown in milk whey than for those grown in conventional medium.38 Also, growth of S. aureus on milk agar masked cell wallassociated components (SPA and teichoic acid) and increased expression of CP.94 Few data are available on the regulation of the expression of surface or extracellular components by S. aureus. However, it has been demonstrated that the synthesis of a number of exoproteins including a, p and 6 toxins, toxic shock syndrome toxin 1 (TSST-l), staphylokinase and SpA was controlled by a locus on the chromosome that was named agr (for accessory gene regulator) and that acts on the transcription of mRNA.lol The existence of a regulatory mechanism of the expression of CP and surface receptors such as Fnbp has yet to be demonstrated.
Pathological modifications to the mammary gland
S. aureus IMI often start with an acute phase with general (fever and anorexia) and local (congestion and hardness of the udder, milk clots) clinical signs. Thereafter, the infection generally becomes chronic and subclinical with sporadic clinical events. Acute gangrenous IMI characterised by a rapid and massive multiplication of bacteria and a general necrosis of the infected quarter is uncommon in cows but frequent in goats and ewes.2o
The pathological changes of the mammary gland during S. aureus infection have been investigated by microscopic examination of sections of mammary glands either naturally infectedlo2. lo3 or experimentally inoculated with bacteria through the teat lo4 or into the parenchyma through the skin. aureus has shown that bacteria can be located in the cytoplasm of epithelial secretory cells.'05 It would be interesting to know if bovine mammary epithelial cells also possess the ability to phagocytose bacteria, as has been shown for bovine endothelial cells.'06 This could be studied by using cultured mammary cells and if such is the case, the role of adhesins in the initial adherence of bacteria to cell membrane and of toxins in the subsequent cell lysis must be clarified.
Bacteria are not always present on injured epithelium or tissue. It seems that toxins and enzymes produced by S . aureus can diffuse in milk and act at a distance from their site of elaboration. Moreover, lysosomal enzymes released by lysed PMNL could contribute to the alteration of mammary glandular epithe1i~m.l~~ Anderson3* 2o stressed the dynamic nature of staphylococcal IMI. Pathological modifications affect variable areas of the gland with variable degrees of severity. Conversion of the infection from subclinical to clinical form could reflect the spreading of bacteria through the gland, which depends on the efficiency of local defence mechanisms.
Role of toxins
S. aureus can produce four different haemolytic toxins : a, p, y and 6 toxins. Two, a and p toxins, appear to play a major role in the virulence of S. aureus. a Toxin, which is produced by between 20%'" and c. 50% (Poutrel, unpublished data) of strains from bovine IMI, is a cytolysin that binds to cell membranes and forms hexameric pores leading to cell death as a consequence of rapid egress of cytoplasmic components.''* p Toxin, a type C sphingomyelinase, is produced by 75-100 % of these ~t r a i n s .~~* '~~ Early studies have shown that systemic vaccination of goats,'1° ewes''' and COWS''^ with a mixture of a and / 3 anatoxins induced serum antibodies specific to a and # l toxins. Vaccination with anatoxins does not lead to the elimination of experimental S. aureus IMI but to a decrease in clinical severity, particularly in small ruminants. This effect can be ascribed to toxin neutralisation by antitoxin antibodies which flow from blood to milk during mammary inflammation.'12 Le Gall and Pl~mrnet''~ have observed that the severity of experimental S. aureus IMI in non-vaccinated ewes is inversely proportional to blood antitoxin antibody titre. Similarly, the blood antitoxin titre in cows increases with age, whereas the incidence of clinical S. aureus IMI d e c r e a s e~.~~ Several recent studies with experimental inoculations of rabbits and mice have confirmed the role of a and / 3 toxins in S. aureus IMI. Injection of purified a toxin into rabbit mammary gland caused haemorrhagic necrosis of the gland whose extent depended on the dose,'14 whereas injection of purified p toxin induced inflammation of the gland, i.e., oedema and a flow of PMNL into mammary ducts and glandular alveoli. Simultaneous injection of both toxins had the same effect as that of purified a toxin a10ne.l'~ In the rabbit two different forms of S. aureus IMI occur: a chronic form with mammary abscesses and a gangrenous form which is often lethal. ' " isolated strains defective in a toxin (non-a), p toxin (non-p) or in both a and / 3 toxins (non-ap strains) expression by directed mutagenesis. The parental and mutant strains were injected into mouse mammary glands to study bacterial growth and pathological lesions in vivo. It was concluded that necrosis of the mammary gland and the high death rate in mice (60 YO) following inoculation of the parental strain was due to a toxin. Both a and / 3 toxins promoted bacterial growth in the mammary gland. However, p toxin appear to contribute little to the pathogenesis of acute mastitis in the mouse model. In the case of non-ap strains, PMNL and cellular architecture of glandular alveoli were not altered, whereas non-p strains caused PMNL lysis, destruction of the secretory epithelium and foci of necrosis. After induction of inflammation by intramammary injection of Escherichia coli lipopolysaccharide, bacterial inoculation caused chronic IMI with all strains, irrespective of toxin expression. Lipopolysaccharide caused an early recruitment of PMNL, which reduced bacterial growth and survival and, therefore, toxin production in milk. This situation, already described,120 could represent the natural chronic S. aureus IMI commonly observed in cows.
Most S. aureus isolates from bovine milk samples Although it is obvious that IMI can be caused by strains which do not produce TSST-1, the role of this toxin has yet to be evaluated.
Role of extracellular enzymes and coagulase
S. aureus produces numerous extracellular en~yrnes'~' including hyaluronidase, phosphatase, nuclease, lipase, catalase, staphylokinase and proteases, that have been implicated in the pathogenesis of bovine IMI. The ability of S. aureus to multiply rapidly in milk is probably a major component of its virulence. Enzymes could allow S. aureus to use milk substrates for their metabolism and, consequently, to adapt to milk and grow.13o However, the involvement of staphylococcal enzymes in the alteration of mammary tissues remains to be demonstrated clearly.
The role of coagulase in the virulence of S. aureus has been mostly studied in the mouse. Injection of purified coagulase into the mouse mammary gland caused a PMNL flow into secretory alveoli and hyperplasia of the mammary epithelium.'" By means of chemical mutagenesis, Kinsman et al.lrs have obtained several coagulase-negative S. aureus mutant strains from an a toxin-producing parental strain. The loss of coagulase entailed a marked decrease of virulence for mouse mammary gland : coagulasenegative mutant strains caused a moderate mammary alteration, whereas the parental strain caused a generalised necrosis. As coagulase has no necrotising activity,'" these observations suggest a synergic effect of coagulase and a toxin. However, Phonimdaeng et all3' failed to confirm these results with site-specific coagulase mutants. This suggests that the earlier findingslls were obtained with strains that had additional mutations on genes encoding other virulence factors. The role of coagulase in bovine IMI remains to be determined. It is noteworthy that most S. aureus isolated from bovine IMI coagulate bovine ~1 a s m a . l~~ However, the relationship between this in-vitro observation and the actual role of coagulase during IMI has never been established.
Conclusions : perspectives of vaccine
During the past two decades, the mouse mammary gland model has been used extensively to study the virulence factors involved in the pathogenesis of S. aureus IMI. This model offers the opportunity to use a large number of animals and given the small size of the glands, to study bacterial growth and the histopathological modifications of the gland in vivo. However, it is likely that results obtained with this model are not fully relevant to natural bovine IMI and, thus, they must always be confirmed by experimental infections of cow udders.
The purpose of vaccination is to increase the efficiency of the natural defences of the mammary gland against S . aureus infection. The ideal vaccine must satisfy the following conditions.' (1) It must induce the appropriate type of immune response. (2) Antigens that lead to undesirable side effects must be excluded from the vaccine, particularly those inducing severe inflammation, i.e., delayed hypersensitivity, which can cause damage to secretory tissues and thus compromise milk production. With vaccines containing toxoids and killed pseudocapsule-producing strains, Watson'33 has shown recently that, following intramammary challenge, vaccinated heifers were more resistant to clinical mastitis and had greater milk production than controls. However, we are convinced that control of immune response and safety of the vaccine could be more easily reached by using selected purified and well-characterised bacterial antigens instead of crude whole-cell preparations.
There is evidence that three major factors could be involved in S. aureus virulence : surface protein receptors to host components such as Fnbp, CP and toxins, particularly a and p toxins. Induction in cows of antibodies against these components could lead to several protective effects : inhibition of S. aureus adhesion to mammary epithelial cells, suppression of resistance to phagocytosis by PMNL and decrease of tissue lesions by neutralisation of toxins. However, the use in vaccination of surface components not involved in virulence but which are potential targets for opsonising antibodies must not be ruled out.
The multiplication of S. aureus in milk before the onset of inflammation is undoubtedly of great importance for the establishment of the infection. It is crucial to obtain a recruitment of activated PMNL into milk of vaccinated animals as early as possible after the entry of S . aureus into the mammary gland. This recruitment does not need to be massive as it is likely that a milk SCC of c. lo6 cells/ml is sufficient to impair staphylococcal IMI,22 but it must coincide with the presence of opsonising antibodies in milk. The immune-mediated recruitment of PMNL in the bovine mammary gland has been demonstrated clearly by De C~e n i n c k . '~~ In cows sensitised to ovalbumin by subcutaneous injection of this protein during lactation, intramammary infusion of ovalbumin elicited inflammation, i.e., release of PMNL into milk. Such a recruitment was not observed in control nonimmunised animals. With a similar experiment in the guinea-pig, De Cueninck has shown that this phenomenon could be transferred by peritoneal cells but not by serum from immunised animals to control animals. 135 Similarly, Rainard et al. 136 have recently immunised cows with purified protein X, a surface antigen of Str. agalactiae. The inflammatory response of the mammary gland, i.e., PMNL recruitment and bactericidal activity of milk, to an experimental infection by a protein X-bearing strain was earlier and much higher in immunised cows than in control cows. Taken together, these results suggest that PMNL functions, including the recruitment into the lumen of the infected mammary gland and the ability to kill invading bacteria, could be increased by immunocompetent cells, presumably T lymphocytes,13' sensitised by vaccination with bacterial protein antigens. Thus, it would be of great interest to determine if immunisation of cows with S. aureus antigens such as Fnbp, anatoxins and CP could induce the recruitment of activated PMNL in the mammary gland during infection by this bacterium.
However, S. aureus CP, which do not carry T cellepitopes, are not good immunogens in cows.138 By Pseudomonas aeruginosa exotoxin A or diphtheria toxoid, increased their immunogenicity and T celldependence in 140 Similar results have been obtained recently in cows with a S . aureus type 5 CPovalbumin ~0 n j u g a t e . l~~ Furthermore, immunisation of mice led to antibodies that promoted opsonisation of S. aureus by human PMNL. 13' Consequently, a vaccine containing purified surface proteins involved in S. aureus adhesion (e.g., Fnbp), a and p anatoxins and CP belonging to predominant serotypes and conjugated to one or several of these proteins could be used to immunise COWS.^*^*^ It is noteworthy that a recent preliminary study has shown that vaccination of cows with a fusion protein containing the Fn-binding domain of Fnbp lead to significant protection against experimental S. aureus IMI, both in terms of clinical signs and reduced SCC.142 Several parameters will need to be investigated to guarantee the efficiency of the proposed conjugate vaccine-the conjugation technique,140 the route and timing of administration and the adjuvant. Once these parameters of vaccination have been optimised, the efficient protection of cows against S. aureus IMI might be feasible.
